✦ LIBER ✦

COX-2 expression is predictive for early relapse and aromatase inhibitor resistance in patients with ductal carcinoma in situ of the breast, and is a target for treatment

✍ Scribed by Generali, D; Buffa, F M; Deb, S; Cummings, M; Reid, L E; Taylor, M; Andreis, D; Allevi, G; Ferrero, G; Byrne, D; Martinotti, M; Bottini, A; Harris, A L; Lakhani, S R; Fox, S B

Book ID: 127186283
Publisher: Nature Publishing Group
Year: 2014
Tongue: English
Weight: 604 KB
Volume: 111
Category: Article
ISSN: 0007-0920
DOI: 10.1038/bjc.2014.236

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Target for Statins, HMG-CoA Reductas

The Target for Statins, HMG-CoA Reductase, Is Expressed in Ductal Carcinoma-In Situ and May Predict Patient Response to Radiotherapy

✍ Butt, Salma; Butt, Talha; Jirström, Karin; Hartman, Linda; Amini, Rose-Marie; Zh 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 551 KB

Cyclooxygenase-2 expression: a potential

Cyclooxygenase-2 expression: a potential prognostic and predictive marker for high-grade ductal carcinoma in situ of the breast

✍ K-B Tan; W-P Yong; T C Putti 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB

p53 Overexpression is a Predictor of Loc

p53 Overexpression is a Predictor of Local Recurrence After Treatment for Both in situ and Invasive Ductal Carcinoma of the Breast

✍ Marnix A. de Roos; Geertruida H. de Bock; Jaap de Vries; Bert van der Vegt; Jell 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 94 KB

Elevated expression of cyclooxygenase-2

Elevated expression of cyclooxygenase-2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma

✍ Carsten Denkert; Klaus-Jürgen Winzer; Berit-Maria Müller; Wilko Weichert; Sören 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 286 KB 👁 3 views

## Abstract ## BACKGROUND Cyclooxygenases regulate the production of prostaglandins and play a role in tumor development and progression. The authors investigated the prognostic impact of expression of the cyclooxygenase (COX) isoforms, COX‐1 and COX‐2, on disease‐free survival and progression‐fre

Should all patients undergoing breast co

Should all patients undergoing breast conserving therapy for DCIS receive radiation therapy? : Yes: Radiation therapy, an important component of breast conserving treatment for patients with ductal carcinoma in situ of the breast

✍ Thomas A. Buchholz; Bruce G. Haffty; Jay R. Harris 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

Can clinical and radiological features p

Can clinical and radiological features predict the need for Sentinel Lymph Node Biopsy in patients with a pre-operative diagnosis of Ductal Carcinoma in Situ, who are eligible for breast conservation surgery?

✍ Samantha Williams; M. Nixon; R. Sutton 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 34 KB